Abstract
The incidence of breast cancer is continuously increasing worldwide, as influenced by many factors that act synergistically. In the last decade there was an increasing interest in the possible viral etiology of human breast cancer. Since then, many viruses have been associated with this disease (murine mammary tumor virus, MMTV; Epstein-Barr virus, EBV; and human papillomavirus, HPV). Recently, BLV has been identified in human breast cancers giving rise to the hypothesis that it could be one of the causative agents of this condition. BLV is a retrovirus distributed worldwide that affects cattle, causing lymphosarcoma in a small proportion of infected animals. Because of its similarity with human retroviruses like HTLV and HIV, BLV was assumed to also be involved in tumor emergence. Based on this assumption, studies were focused on the possible role of BLV in human breast cancer development. We present a compilation of the current knowledge on the subject and some prospective analysis that is required to fully end this controversy.
Similar content being viewed by others
Abbreviations
- BRCA:
-
Breast cancer 1
- CDH 1:
-
Caderin 1
- PTEN:
-
Phosphatase and tensin homolog
- STK11:
-
Serine/threonine kinase 11
- TP53:
-
Tumor promoter 53
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
American Cancer Society. Cancer facts & figures 2017. Atlanta: American Cancer Society; 2017.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.
Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E. Breast cancer risk factors. Prz Menopauzalny. 2015;14(3):196–202.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics. CA Cancer J Clin. 2015;65(2):87–108.
Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124(1):31–42.
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–16.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.
Sarid R, Gao SJ. Viruses and human cancer: from detection to causality. Cancer Lett. 2011;305(2):218–27.
Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992;21(2):95–100.
Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, et al. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res. 1995;55(22):5173–9.
Ochoa Cruz A, Uribe A, Gutiérrez M. Estudio del potencial zoonótico del virus de la leucosis bovina y su presencia en casos de cáncer de seno. Univ Sci. 2006;11(2):31–40.
Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G. Bovine leukemia virus DNA in human breast tissue. Emerg Infect Dis. 2014;20(5):772–82.
Aida Y, Murakami H, Takahashi M, Takeshima SN. Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol. 2013;4:328.
Panei CJ, Takeshima S, Omori T, Nunoya T, Davis WC, Ishizaki H, et al. Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR. BMC Vet Res. 2013;9:95.
Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology. 2007;4:18.
Rodríguez SM, Florins A, Gillet N, de Brogniez A, Sánchez-Alcaraz MT, Boxus M, et al. Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses. 2011;3:1210–48.
Hopkins SG, Di Giacomo RF. Natural transmission of bovine leukemia virus in dairy and beef cattle. Vet Clin North Am Food Anim Pract. 1997;13(1):107–28.
Lassauzet ML, Thurmond MC, Johnson WO, Stevens F, Picanso JP. Factors associated with transmission of bovine leukemia virus by contact in cows on a California dairy. Am J Epidemiol. 1991;133(2):164–76.
Gutiérrez G, Lomonaco M, Alvarez I, Fernandez F, Trono K. Characterization of colostrum from dams of BLV endemic dairy herds. Vet Microbiol. 2015;177(3–4):366–9.
Van Der Maaten MJ, Miller JM, Schmerr MJF. Effect of colostral antibody on bovine leukemia virus infection of neonatal calves. Am J Vet Res. 1981;42:1498–500.
Van der Maaten MJ, Miller JM, Schmerr MJ. In utero transmission of bovine leukemia virus. Am J Vet Res. 1981 Jun;42(6):1052–4.
Lewinski MK, Bushman FD. Retroviral DNA integration--mechanism and consequences. Adv Genet. 2005;55:147–81.
Murakami H, Yamada T, Suzuki M, Nakahara Y, Suzuki K, Sentsui H. Bovine leukemia virus integration site selection in cattle that develop leukemia. Virus Res. 2011;156(1–2):107–12.
Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, et al. Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci. 2007;12:1520–31.
Buehring GC, Philpott SM, Choi KY. Humans have antibodies reactive with Bovine leukemia virus. AIDS Res Hum Retrovir. 2003;19(12):1105–13.
Sommerfelt MA. Retrovirus receptors. J Gen Virol. 1999;80:3049–64.
Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115(4):449–59.
Suzuki T, Matsubara Y, Kitani H, Iked H. Evaluation of the d subunit of bovine adaptor protein complex 3 as a receptor for bovine leukaemia virus. J Gen Virol. 2003;84:1309–16.
Robinson MS, Bonifacino JS. Adaptor-related proteins. Curr Opin Cell Biol. 2001;4:444–53.
Graves DC, Ferrer JF. In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures. Cancer Res. 1976;36:4152–9.
Olaya-Galán NN, Corredor-Figueroa AP, Guzmán-Garzón TC, Ríos-Hernandez KS, Salas-Cárdenas SP, Patarroyo MA, et al. Bovine leukaemia virus DNA in fresh milk and raw beef for human consumption. Epidemiol Infect. 2017;145:3125–30.
Buehring GC, Shen HM, Jensen HM, Jin DL, Hudes M, Block G. Exposure to bovine leukemia virus is associated with breast cancer: a case-control study. PLoS One. 2015;10(9):e0134304.
Gross C, Thoma-Kress AK. Molecular mechanisms of HTLV-1: cell-to-cell transmission. Viruses. 2016;8(3):74.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer . 2007, 90:1–636.
Carneiro-Proietti ABF, Amaranto-Damasio MS, Leal-Horiguchi CF, Bastos RHC, Seabra-Freitas G, Borowiak DR, et al. Mother-to-child transmission of human T-cell lymphotropic viruses-1/2: what we know, and what are the gaps in understanding and preventing this route of infection. J Pediatric Infect Dis Soc. 2014;3(Suppl 1):S24–9.
Miyasaka T, Oguma K, Sentsui H. Distribution and characteristics of bovine leukemia virus integration sites in the host genome at three different clinical stages of infection. Arch Virol. 2015;160:39–46.
Takahashi M, Tajima S, Okada K, Davis WC, Aida Y. Involvement of bovine leukemia virus in induction and inhibition of apoptosis. Microbes Infect. 2004;7:19–28.
Twizere JC, Kruys V, Lefèbvre L, Vanderplasschen A, Collete D, Debacq C, et al. Interaction of retroviral tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst. 2003;95(24):1846–59.
Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R, et al. Lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia/lymphoma (ATL). Iran J Basic Med Sci. 2013;16:179–95.
Buehring GC, Kramme PM, Schultz RD. Evidence for bovine leukemia virus in the mammary epithelial cells of infected cows. Lab Investig. 1994;71:359–65.
Yoshinaka YK. Bovine leukemia virus protease: pirufication, chemical analysis, and in vitro processing of gag precursos polyproteins. J Virol. 1986;57:826–32.
Mesa G, Ulloa JC, Uribe AM, Gutierrez MF. Bovine leukemia virus gene segment detected in human breast tissue. Open J Med Microbiol 2013; 3: (1)84–90.
Buehring GC, Shen H, Schwartz DA, Lawson JS. Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development. PLoS One. 2017;12(6):e0179367.
Zhang R, Jiang J, Sun W, Zhang J, Huang K, Gu X, et al. Lack of association between bovine leukemia virus and breast cancer in Chinese patients. Breast Cancer Res. 2016;18:101.
Buehring GC. Response to “lack of association between bovine leukemia virus and breast cancer in Chinese patients”. Breast Cancer Res. 2017;19:24.
Choi KY, Liu RB, Buehring GC. Relative sensitivity and specificity of agar gel immunodiffusion, enzyme immunosorbent assay, and immunoblotting for detection of anti-bovine leukemia virus antibodies in cattle. J Virol Methods. 2002;104:33–9.
Gillet N, Willems L. Whole genome sequencing of 51 breast cancers reveals that tumors are devoid of bovine leukemia virus DNA. Retrovirology. 2016;13:75.
Baltzell KA, Shen HM, Krishnamurty S, Sison JD, Nuovo GJ, Buehring GC. Bovine leukemia virus linked to breast cancer but not coinfection with human papillomavirus: case-control study of women in Texas. Cancer. 2018;124(7):1342–9.
Frie MC, Coussensa PM. Bovine leukemia virus: a major silent threat to proper immune responses in cattle. Vet Immunol Immunopathol. 2015;163(3–4):103–14.
Schiller JT, Lowy DR. Virus infection and human cancer: an overview. Recent Results Cancer Res. 2014;193:1–10.
Chen CJ, Hsu W, Yang H, Lee M, Chen H, Chien Y, et al. Epidemiology of virus infection and human cancer. Recent Results Cancer Res. 2014;193:11–32.
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
He Y, Yang X, Xia J, Zhao L, Yang Y. Consumption of meat and dairy products in China: a review. Proc Nutr Soc. 2016;75:385–91.
Lawson JS, Salmons B, Glenn WK. Oncogenic viruses and breast cancer: mouse mammary tumor virus (MMTV), bovine leukemia virus (BLV), human papilloma virus (HPV), and Epstein - Barr virus (EBV). Front Oncol. 2018;8:1.
Lawson JS, Salmons B, Gunzburg WH. Commentary regarding Gannon et al. “viral infections and breast cancer e A current perspective”. Cancer Lett. 2018;424:117e118.
Vinner L, Mourier T, Friis-Nielsen J, Gniadecki R, Dybkaer K, Rosenberg J, et al. Investigation of human cancers for retrovirus by low-stringency target enrichment and high-throughput sequencing. Sci Rep. 2015;5:13201.
Read SA, Douglas MW. Virus induced inflammation and cancer development. Cancer Lett. 2014;345(2):174–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martinez Cuesta, L., Lendez, P.A., Nieto Farias, M.V. et al. Can Bovine Leukemia Virus Be Related to Human Breast Cancer? A Review of the Evidence. J Mammary Gland Biol Neoplasia 23, 101–107 (2018). https://doi.org/10.1007/s10911-018-9397-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10911-018-9397-z